COVID drug Paxlovid, which helps prevent severe symptoms, will double in price as pandemic ebbsPaxlovid, an antiviral therapy that is prescribed to COVID-19 patients to prevent severe illness, soon will become much more expensive to obtain. "The commercial transition will begin in November 2023, as the U.S. government begins to discontinue the distribution of EUA-labeled Paxlovid," Pfizer wrote. "The commercial transition will begin in November 2023, as the U.S. government begins to discontinue the distribution of EUA-labeled Paxlovid," Pfizer wrote. The date May 11, 2023, marked the official end of the federal public health emergency related to the COVID-19 pandemic. Original article source: COVID drug Paxlovid, which helps prevent severe symptoms, will double in price as pandemic ebbs

Source: Fox News October 21, 2023 11:58 UTC